Automated Endoscope Reprocessors Market, By Product Type (Single Basin AER, Dual Basin AER), By Modality (Standalone AER, Bench top AER), By End User (Hospitals, Ambulatory Surgical Centers, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Jul 2020

Code : CMI4046

Pages :182

Formats :

Excel and PDF

Industry : Medical Devices

Automated Endoscope Reprocessors MarketSize and Trends

The global automated endoscope reprocessors market is estimated to account for US$ 424.8 Mn in terms of value and is expected to reach US$ 706.3 Mn by the end of 2027.

Single Basin AER held dominant position in the global automated endoscope reprocessors market in 2019, accounting for 50.02% share in terms of value, followed by Dual Basin AER.

The global automated endoscope reprocessors market was valued at US$ 394.8 Mn in 2019 and is forecast to reach a value of US$ 706.3 Mn by 2027 at a CAGR of 7.4% between 2020 and 2027.

Figure 2. Global Automated Endoscope Reprocessors Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

Approval and launch of new devices is expected to propel growth of the global automated endoscope reprocessors market. For instance, in April 2018, The U.S. Food and Drug Administration announced that Custom Ultrasonics completed validation testing of its System Plus automated endoscope reprocessors, and that the devices are cleared for the reprocessing of certain duodenoscopes.

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in October 2019, Cantel Medical Corp. acquired Hu-Friedy Mfg. Co LLC, a manufacturer of instruments and instrument reprocessing workflow systems.